• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Racial Disparities in Diagnosis and Prognosis of Nonalcoholic Fatty Liver Disease.

作者信息

Samji Naga Swetha, Snell Peter D, Singal Ashwani K, Satapathy Sanjaya K

机构信息

Department of Internal Medicine Tennova Cleveland Hospital Cleveland TN.

Department of Internal Medicine University of Tennessee Health Science Center Memphis TN.

出版信息

Clin Liver Dis (Hoboken). 2020 Sep 4;16(2):66-72. doi: 10.1002/cld.948. eCollection 2020 Aug.

DOI:10.1002/cld.948
PMID:32922753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7474141/
Abstract
摘要

相似文献

1
Racial Disparities in Diagnosis and Prognosis of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病诊断与预后中的种族差异
Clin Liver Dis (Hoboken). 2020 Sep 4;16(2):66-72. doi: 10.1002/cld.948. eCollection 2020 Aug.
2
Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.美国非酒精性脂肪性肝病患病率、严重程度和结局的种族和民族差异：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2018 Feb;16(2):198-210.e2. doi: 10.1016/j.cgh.2017.09.041. Epub 2017 Sep 29.
3
Nonalcoholic fatty liver disease: diagnosis and management.非酒精性脂肪性肝病：诊断与管理。
Am Fam Physician. 2013 Jul 1;88(1):35-42.
4
Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis.非酒精性脂肪性肝病临床试验入组中的种族差异：一项系统评价和荟萃分析。
World J Hepatol. 2020 Aug 27;12(8):506-518. doi: 10.4254/wjh.v12.i8.506.
5
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee.非酒精性脂肪性肝病诊断和治疗实践指南。意大利肝病学会（AISF）专家委员会十项建议。
Dig Liver Dis. 2010 Apr;42(4):272-82. doi: 10.1016/j.dld.2010.01.021. Epub 2010 Feb 19.
6
Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health.非酒精性脂肪性肝病：一种疾病，多种肝脏健康影响。
Cell Biol Toxicol. 2017 Feb;33(1):5-14. doi: 10.1007/s10565-016-9361-x. Epub 2016 Sep 28.
7
Nonalcoholic fatty liver disease in the pediatric population: a review.儿科人群中的非酒精性脂肪性肝病：综述
Curr Opin Pediatr. 2005 Oct;17(5):636-41. doi: 10.1097/01.mop.0000172816.79637.c5.
8
Nonalcoholic fatty liver and the severity of acute pancreatitis.非酒精性脂肪肝与急性胰腺炎的严重程度。
Eur J Intern Med. 2017 Mar;38:73-78. doi: 10.1016/j.ejim.2016.10.019. Epub 2016 Nov 5.
9
Nonalcoholic Fatty Liver Disease vs. Nonalcoholic Steatohepatitis: Pathological and Clinical Implications.非酒精性脂肪性肝病与非酒精性脂肪性肝炎：病理与临床意义。
Curr Vasc Pharmacol. 2018;16(3):214-218. doi: 10.2174/1570161115666170621075157.
10
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.

引用本文的文献

1
() rs738409 Variant and Non-Alcoholic Fatty Liver Disease Risk in Vietnamese Working-Age Adults: A Case-Control Study with Metabolic Insights.越南劳动年龄成年人中 rs738409 变异与非酒精性脂肪性肝病风险：一项具有代谢见解的病例对照研究
Clin Exp Gastroenterol. 2025 Aug 29;18:191-204. doi: 10.2147/CEG.S532528. eCollection 2025.
2
Managing Nonalcoholic Fatty Liver Disease Through Structured Lifestyle Modification Interventions.通过结构化生活方式改变干预措施管理非酒精性脂肪性肝病
Am J Lifestyle Med. 2025 May 26:15598276251346717. doi: 10.1177/15598276251346717.
3
Clinical Phenotypes May be Able to Identify Populations With Nonalcoholic Fatty Liver-Spectrum Disease.临床表型或许能够识别出患有非酒精性脂肪性肝病谱疾病的人群。
Gastro Hep Adv. 2025 Jan 3;4(5):100611. doi: 10.1016/j.gastha.2024.100611. eCollection 2025.
4
Social Determinants of Health Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence and Severity: A Systematic Review and Meta-Analysis.与代谢功能障碍相关脂肪性肝病患病率及严重程度相关的健康社会决定因素：一项系统评价和荟萃分析
Am J Gastroenterol. 2025 Mar 17. doi: 10.14309/ajg.0000000000003421.
5
Racial Disparities in Mortality Rates among Patients with Hepatic Steatosis, Non-Alcoholic Fatty Liver Disease, and Non-Alcoholic Steatohepatitis: Insights from NHANES III Data.肝脂肪变性、非酒精性脂肪性肝病和非酒精性脂肪性肝炎患者死亡率的种族差异：来自美国国家健康和营养检查调查（NHANES）III数据的见解
J Racial Ethn Health Disparities. 2025 Mar 4. doi: 10.1007/s40615-025-02317-9.
6
Intervening on Metabolic Dysfunction-Associated Steatotic Liver Disease in Latino/a and Black Patients with Diabetes: A Feasibility Pilot.对拉丁裔和黑人糖尿病患者的代谢功能障碍相关脂肪性肝病进行干预：一项可行性试点研究
Diabetes Ther. 2024 Nov;15(11):2417-2427. doi: 10.1007/s13300-024-01651-1. Epub 2024 Sep 14.
7
Characterization of an At-Risk Population for Nonalcoholic Fatty Liver Disease (NAFLD) in a Primary Care Setting Along the U.S.-Mexico Border.美国-墨西哥边境基层医疗环境中，非酒精性脂肪性肝病（NAFLD）高危人群的特征分析
J Transcult Nurs. 2025 Jan;36(1):92-102. doi: 10.1177/10436596241271265. Epub 2024 Aug 27.
8
Prevalence and Characteristics of Metabolic Dysfunction-Associated Fatty Liver Disease among an Iranian Adult Population with Ethnic and Genetic Diversity: Results of the PolyIran-Liver Study.伊朗具有种族和基因多样性的成年人群中代谢功能障碍相关脂肪性肝病的患病率及特征：PolyIran-肝脏研究结果
Middle East J Dig Dis. 2024 Apr;16(2):86-95. doi: 10.34172/mejdd.2024.374. Epub 2024 Apr 30.
9
Manifestation and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease in a Predominately African American Population at a Multi-Specialty Healthcare Organization.在一家多专科医疗保健机构中，以非裔美国人为主的人群中代谢功能障碍相关脂肪性肝病的表现与进展
Healthcare (Basel). 2024 Jul 25;12(15):1478. doi: 10.3390/healthcare12151478.
10
Racial Disparities in Evidence-Based Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes.种族差异与 2 型糖尿病代谢相关脂肪性肝病患者的基于证据的管理。
Endocr Pract. 2024 Jul;30(7):663-669. doi: 10.1016/j.eprac.2024.04.018. Epub 2024 May 1.

本文引用的文献

1
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的流行病学、风险评估及诊断挑战
Medicines (Basel). 2019 Mar 18;6(1):41. doi: 10.3390/medicines6010041.
2
Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review.非酒精性脂肪性肝病与心脏：美国心脏病学会的现状评价。
J Am Coll Cardiol. 2019 Mar 5;73(8):948-963. doi: 10.1016/j.jacc.2018.11.050.
3
American Ancestry Is a Risk Factor for Suspected Nonalcoholic Fatty Liver Disease in Hispanic/Latino Adults.美国血统是西班牙裔/拉丁裔成年人疑似非酒精性脂肪性肝病的一个风险因素。
Clin Gastroenterol Hepatol. 2019 Oct;17(11):2301-2309. doi: 10.1016/j.cgh.2019.02.007. Epub 2019 Feb 8.
4
Prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States.美国亚裔成年人中非酒精性脂肪性肝病（NAFLD）的患病率和结局。
Liver Int. 2019 Apr;39(4):748-757. doi: 10.1111/liv.14038. Epub 2019 Feb 13.
5
Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.影响脂肪性肝炎中肝细胞癌的代谢因素。
Liver Int. 2019 Mar;39(3):531-539. doi: 10.1111/liv.14002. Epub 2018 Dec 2.
6
Response to Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187-192.对关于布里尔等人的评论的回应。非裔美国患者非酒精性脂肪性肝炎的临床和组织学特征。《糖尿病护理》2018年；41:187 - 192。
Diabetes Care. 2018 Sep;41(9):e137-e138. doi: 10.2337/dci18-0026.
7
Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.美国肝硬化和肝细胞癌基于病因和种族的年度死亡率变化趋势。
Hepatology. 2019 Mar;69(3):1064-1074. doi: 10.1002/hep.30161. Epub 2019 Feb 11.
8
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.非酒精性脂肪性肝炎是肝移植候选者中肝细胞癌增长最快的病因。
Clin Gastroenterol Hepatol. 2019 Mar;17(4):748-755.e3. doi: 10.1016/j.cgh.2018.05.057. Epub 2018 Jun 14.
9
Metabolic Features of Nonalcoholic Fatty Liver (NAFL) in Obese Adolescents: Findings From a Multiethnic Cohort.肥胖青少年非酒精性脂肪肝的代谢特征：一项多民族队列研究的结果。
Hepatology. 2018 Oct;68(4):1376-1390. doi: 10.1002/hep.30035.
10
Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent.在南亚裔人群中，脂肪性肝病中肝纤维化的非侵入性标志物不可靠。
Frontline Gastroenterol. 2018 Apr;9(2):115-121. doi: 10.1136/flgastro-2017-100865. Epub 2017 Nov 16.